Geno J Germano
CIK 1424383 · President · last filed 2026-08-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.69M
Companies
11
Total Filings
97
Lifetime Open-Market Net
-$1.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTX | Director | 65,014 | $3.00 | $195.0K | $55.8K | 3 | 2026-08-07 |
| DTIL | Director | 44,883 | $7.50 | $336.6K | $47.6K | 12 | 2026-06-05 |
| HRMY | Director | — | $39.52 | — | $0 | 1 | 2026-05-18 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | — | $8.68 | — | $0 | 12 | 2025-07-31 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 0 | — | — | $0 | 4 | 2020-01-06 |
| Bioverativ Inc. (BIVV) Delisted | Director | — | — | — | $0 | 3 | 2018-03-08 |
| PRECIGEN, INC. (XON) Delisted | President | — | — | — | $0 | 3 | 2016-09-26 |
| PFE | Group President | 367,537 | $26.62 | $9.78M | -$1.12M | 49 | 2015-02-27 |
| PFIZER INC (PFE.WD) Delisted | Business Unit President | 227,457 | — | — | $0 | 2 | 2013-06-28 |
| ZTS | Director | 5,000 | $75.35 | $376.8K | $130.0K | 1 | 2013-02-08 |
| WYETH (WYE) Delisted | Pres.-US Pharm. & Wom. Health. | 44,893 | — | — | -$179.4K | 6 | 2009-04-29 |
Recent Filings · Page 8 of 10
97 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-01-02 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-12-17 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-12-03 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-11-19 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-11-01 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-10-16 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-10-01 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-09-18 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-09-04 | PFE | Grant (A) | — | $0 | EDGAR |
| 2012-08-16 | PFE | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.